PP
Therapeutic Areas
Yellowstone Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Platform Program | Acute Myeloid Leukemia (AML) & other cancers | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Undisclosed Platform Program | Acute Myeloid Leukemia (AML) & other cancers | Preclinical |